| Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621) |
|---|
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | US20040087813 Methods of chemical systhesis of phenolic nitrogen mustard prodrugs |
| 05/06/2004 | US20040087812 E.g., dibutyltin dithiocyanate and dibromotetrabutyldistannoxane |
| 05/06/2004 | US20040087792 Tryptase-inhibitors |
| 05/06/2004 | US20040087791 Bis(substituted propynyl)-substituted benzenes, pyridines, pyrimidines, pyrazines, pyridines, furans and pyrroles; e.g., 3,5-bis-(3-(4-aminomethylbenzylaminocarbonyloxy)prop-1-ynyl)--1 -hydroxymethylbenzene |
| 05/06/2004 | US20040087747 Acrylic polymers containing pendant primary carbamate groups, a method of making said polymers, and curable coating compositions containing said polymers |
| 05/06/2004 | US20040087738 Compounds having a secondary or tertiary hydroxy or halide group separated from a primary carbamate group by three or more carbon atoms and a method of making the same |
| 05/06/2004 | US20040087731 Method of making a curable coating composition containing a carbamate functional reactive additive |
| 05/06/2004 | EP1415659A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/06/2004 | EP1414792A1 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates |
| 05/06/2004 | EP1414791A1 Method for the production of 1,2,4-triaminobenzolecarbamic acid esters |
| 05/06/2004 | EP1414787A1 New derivatives of substituted anilines with herbicidal activity |
| 05/06/2004 | EP1414434A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 05/06/2004 | CA2503452A1 N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them |
| 05/05/2004 | CN1494540A Amino alcohol derivatives |
| 05/05/2004 | CN1494527A Or tho-substituted and meta-substituted bis-aryl compounds, method for production thereof, their use as medicament, and pharmaceutical preparations containing there compounds |
| 05/05/2004 | CN1494425A Carboxamide derivatives as therapeutic agents |
| 04/29/2004 | US20040082820 Hydrogen transfer reduction; useful as intermediate for production of pharmaceuticals/agricultural chemicals |
| 04/29/2004 | US20040082683 Dental materials with extendable work time, kits, and methods |
| 04/29/2004 | US20040082623 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 04/29/2004 | US20040082601 Anti-inflammatory compounds |
| 04/29/2004 | US20040082496 For the treatment of body weight disorders (obesity/anorexia/ bulemia/cachexia) |
| 04/28/2004 | EP1413569A1 Bicyclic cyclopropane derivatives capable of polymerisation and their use in the preparation of dental materials |
| 04/28/2004 | EP1412334A1 Pyrazoline derivatives and their use as pesticides |
| 04/28/2004 | EP1412319A1 Chiral resolution method for producing compounds useful in the synthesis of taxanes |
| 04/28/2004 | EP0840741B1 Pna-dna chimeras and pna synthons for their preparation |
| 04/28/2004 | EP0585366B1 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 04/28/2004 | EP0558648B1 Improved matrix metalloprotease inhibitors |
| 04/27/2004 | US6727392 Such as 4b(s)-benzyl-7(s)-hydroxy-7(s)-(3,3,3-trifluoropropyl)4,5,6,7,8,8a(r),9,10 -octahydro-phenanthrene-2-carboxylic acid (2-methyl-pyridin-3-ylmethyl)-amide via catalytic reduction; transcription factors |
| 04/27/2004 | US6727318 Method for producing aqueous polymer dispersions containing colorants |
| 04/27/2004 | US6727255 Brain, nervous system and psychological disorders |
| 04/27/2004 | US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 04/27/2004 | US6727239 Inhibitory activity on no- synthase enzymes producing nitrogen monoxide no and/or an activity which traps the reactive oxygen species (ros) |
| 04/22/2004 | WO2004033422A2 Modulation of anxiety through blockade of anandamide hydrolysis |
| 04/22/2004 | WO2004013077A3 Cyclopentanone and cyclopentanone derivatives as potent activators of hsf-1 |
| 04/22/2004 | US20040077882 Polymerizable bicyclic cyclopropane derivatives and their use for the preparation of dental materials |
| 04/22/2004 | US20040077881 $G(d)1-pyrrolines used in pest control |
| 04/22/2004 | US20040077829 Modified peptide derivatives and methods of use thereof |
| 04/22/2004 | US20040077691 Hydroxamate derivatives of non-steroidal anti-inflammatory drugs |
| 04/22/2004 | US20040077628 Melanin-concentrating hormone antagonist |
| 04/22/2004 | US20040077553 Such as 1-(((alpha-propanoyloxybutoxy)carbonyl)aminomethyl)-1-cyclohexane acetic acid; ability to cross blood brain barrier; sustained release |
| 04/22/2004 | CA2501506A1 Modulation of anxiety through blockade of anandamide hydrolysis |
| 04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 04/21/2004 | CN1491211A G(D)1-pyrrolines used in pest control |
| 04/21/2004 | CN1146552C Azulene hydroxamic acid derivatives as metalloprotein inhibitors |
| 04/20/2004 | US6723868 Process for the preparation of aminoalcohol derivatives and their further conversion to (1R,4S)-4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino)-2-cyclopentenyl-1-methanol |
| 04/20/2004 | US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 04/20/2004 | US6723745 Prevention or treatment of autoimmune disease in warm blooded animal |
| 04/15/2004 | WO2002000611A9 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 04/15/2004 | US20040073065 Fluorine compound and fluorinating agent comprising the compound |
| 04/15/2004 | US20040072907 Antipicornaviral compounds, compositions containing them, and methods for their use |
| 04/15/2004 | US20040072878 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 04/15/2004 | US20040072854 Antiemetics; psychlogical disorders; antidepressants; anxiolytic agents; antitussive agents |
| 04/15/2004 | US20040072690 Such as (R)-3-(4-(2-(3-(2,4-difluorophenyl)-1-heptylureido) ethoxy)phenyl)-2-ethoxypropionic acid; for prophylaxis/therapy of diabetes/hyperlipidemia |
| 04/14/2004 | EP1408027A1 DIAMINE DERIVATIVE,PROCESS FOR PRODUCING THE SAME, AND BACTERICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT |
| 04/14/2004 | EP1406617A1 Diaminediols for the treatment of alzheimer's disease |
| 04/14/2004 | EP1305270B1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids |
| 04/14/2004 | EP1161416B1 Alpha-aminoacetic acid derivatives useful as alpha 4 beta 7 - receptor antagonists |
| 04/14/2004 | EP1054907B1 Method for producing aqueous polymer dispersions containing colorants |
| 04/14/2004 | CN1488623A Method for preparing 2,4-toluene diamino menthyl formate |
| 04/13/2004 | US6720421 Storage stability: good raw-stock storability before recording and good image storability after recording |
| 04/08/2004 | WO2004016580A3 Derivatives of glycinergic r(+)-2-amino-3-hydroxypropanoic acid |
| 04/08/2004 | WO2003106399A3 PROCESS FOR PREPARING N-PROTECTED beta-AMINO ALDEHYDE COMPOUNDS |
| 04/08/2004 | US20040067981 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants |
| 04/08/2004 | US20040067969 Syntheses of quinazolinones |
| 04/08/2004 | US20040067525 Method for structural analysis of organic compound |
| 04/08/2004 | US20040067229 Azobenzene derivatives as labeling agents and intermediates thereof |
| 04/07/2004 | EP1404652A1 A novel alkaloid derivative and a pharmaceutical composition containing the same |
| 04/07/2004 | EP1404328A1 Alpha-hydroxyamide statine derivatives for the treatment of alzheimer's disease |
| 04/07/2004 | EP1404324A2 Prodrugs of gaba analogs, compositions and uses thereof |
| 04/07/2004 | EP1404310A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 04/07/2004 | CN1486973A Ethyl methyl 3-[(1s)-1-(dimethylamino) ethyl] phenyl carbamate and its prepn and medicine use |
| 04/07/2004 | CN1144793C Polar-substituted hydrocarbons |
| 04/06/2004 | US6717013 Easily attained with high positional selectivity and yield; intermediates and raw materials |
| 04/06/2004 | US6717012 Such as alpha-phenyl-n-(7-tert-butoxycarbonylamino-3,5-dimethyladamantane)nitrone for treatment of neurological/ inflammatory diorders, and aging, which result from the overproduction of nitric oxide |
| 04/06/2004 | US6716980 Cyclization and acylation of carbamate |
| 04/06/2004 | US6716818 Caspase inhibitors and the use thereof |
| 04/06/2004 | CA2067381C Treatment of hiv infections and compounds useful therein |
| 04/01/2004 | WO2004026817A1 Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| 04/01/2004 | WO2004026815A2 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | WO2004026814A2 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors |
| 04/01/2004 | WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 04/01/2004 | WO2003082777A3 Novel glucocorticoid receptor ligands |
| 04/01/2004 | WO2003075853A3 Cyclic derivatives as modulators of chemokine receptor activity |
| 04/01/2004 | WO2002076402A3 Fatty amine drug conjugates |
| 04/01/2004 | US20040063999 Process for the production of optically active amino alcohols |
| 04/01/2004 | US20040063959 Esters and amides as PLA2 inhibitors |
| 04/01/2004 | US20040063904 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063679 Amidino and guanidino peptidyl compounds; autoimmune diseases |
| 04/01/2004 | CA2498759A1 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors |
| 04/01/2004 | CA2498662A1 Phenol derivatives and their use as rotamase inhibitors |
| 03/31/2004 | EP1402888A1 The use of substituted carbocyclic compounds as rotamases inhibitors |
| 03/31/2004 | EP1401803A2 Method for producing chiral amino acid derivatives |
| 03/31/2004 | EP1401434A1 Modulators of peroxisome proliferator activated receptors (ppar) |
| 03/31/2004 | EP1210324B1 Substituted cyclopentenes, their preparation and their use for chiral scaffolds |
| 03/31/2004 | EP1037865A4 Synthesis of cc-1065/duocarmycin analogs |
| 03/31/2004 | CN1486298A Prodrugs of excitatory amino acids |
| 03/30/2004 | US6713641 Reactive anthraquinone colorant compounds and polymeric materials reacted therewith |